Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 19.91 CNY -0.8% Market Closed
Market Cap: 56.7B CNY
Have any thoughts about
Shanghai Pharmaceuticals Holding Co Ltd?
Write Note

Shanghai Pharmaceuticals Holding Co Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Pharmaceuticals Holding Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
EPS (Diluted)
ÂĄ1
CAGR 3-Years
-17%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Sinopharm Group Co Ltd
HKEX:1099
EPS (Diluted)
ÂĄ2
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-38%
CAGR 5-Years
-12%
CAGR 10-Years
2%
C
China National Medicines Corp Ltd
SSE:600511
EPS (Diluted)
ÂĄ2
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
11%
Huadong Medicine Co Ltd
SZSE:000963
EPS (Diluted)
ÂĄ1
CAGR 3-Years
12%
CAGR 5-Years
4%
CAGR 10-Years
16%
C
China National Accord Medicines Corp Ltd
SZSE:000028
EPS (Diluted)
ÂĄ2
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
4%
No Stocks Found

Shanghai Pharmaceuticals Holding Co Ltd
Glance View

Market Cap
56.7B CNY
Industry
Health Care

Shanghai Pharmaceuticals Holding Co Ltd, a giant in China's pharmaceutical industry, operates with a dual-engine strategy that seamlessly combines manufacturing and distribution. Established in the bustling metropolis of Shanghai, the company has swiftly become a cornerstone of China's healthcare landscape. Its manufacturing arm is a powerhouse of innovation and production, turning out a vast array of pharmaceutical products that encompass both traditional Chinese medicine and modern pharmaceuticals. These products range from patented medicines to essential generics, entering hospitals, clinics, and retail pharmacies nationwide, all the while feeding a robust supply chain that caters to the country's vast and diverse market needs. On the flip side, Shanghai Pharmaceuticals' extensive distribution network is the lifeline that ensures these vital medicines reach their destinations safely and efficiently. In an era where logistics and supply chain management are pivotal, the company excels through an advanced distribution system that connects manufacturers with end-users across China. This network is bolstered by strategic partnerships and a commitment to technological advancement, allowing the company to maintain agility and reliability in an ever-evolving market. Revenue streams flow not just from product sales but are heavily supplemented through strategic partnerships and services that enhance accessibility and affordability for healthcare providers and patients alike. As one of the top pharmaceutical firms in China, Shanghai Pharmaceuticals is adept at maneuvering the intricacies of healthcare demands, regulatory landscapes, and competitive dynamics, carving its niche as a leader in both innovation and distribution efficiency.

Intrinsic Value
45.73 CNY
Undervaluation 56%
Intrinsic Value
Price

See Also

What is Shanghai Pharmaceuticals Holding Co Ltd's EPS (Diluted)?
EPS (Diluted)
1.1 CNY

Based on the financial report for Sep 30, 2024, Shanghai Pharmaceuticals Holding Co Ltd's EPS (Diluted) amounts to 1.1 CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
2%

Over the last year, the EPS (Diluted) growth was -13%. The average annual EPS (Diluted) growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been -17% over the past three years , -5% over the past five years , and 2% over the past ten years .

Back to Top